Cardiovascular disease in menopause: Does the obstetric history have any bearing?

Menopause International

Volumn 19, Issue 3, 2013, Pages 115-120

  Mahendru, Amita A ^a   Morris, Edward ^b  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular disease; Intrauterine growth restriction; Preeclampsia; Pregnancy loss; Preterm labour

Indexed keywords

ANDROGEN; DIPEPTIDYL CARBOXYPEPTIDASE; ESTROGEN; ESTROGEN RECEPTOR; ICOSANOID; NITRIC OXIDE;

ADRENERGIC SYSTEM; ANDROGEN BLOOD LEVEL; ARTERIAL BLOOD; ARTERIAL STIFFNESS; ATHEROSCLEROTIC PLAQUE; AUGMENTATION INDEX; BIRTH WEIGHT; BLOOD VESSEL WALL; BLOOD VISCOSITY; BLOOD VOLUME; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CAROTID ARTERY INTIMA THICKNESS; CEREBROVASCULAR ACCIDENT; CLIMACTERIUM; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; EARLY MENOPAUSE; ENDOTHELIAL DYSFUNCTION; ESTROGEN BLOOD LEVEL; ESTROGEN DEFICIENCY; FAMILY HISTORY; FETUS GROWTH; FIRST TRIMESTER PREGNANCY; HEART FUNCTION; HEART INDEX; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE METABOLISM; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INTRAUTERINE GROWTH RESTRICTION; ISCHEMIC HEART DISEASE; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MATERNAL HYPERTENSION; MEDICAL HISTORY; MENOPAUSE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OBSTETRIC HISTORY; OXIDATIVE STRESS; POSTMENOPAUSE; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PREVALENCE; PROGENY; PULSE WAVE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SPONTANEOUS ABORTION; SYSTEMIC VASCULAR RESISTANCE; THIRD TRIMESTER PREGNANCY; THROMBOCYTE AGGREGATION; THROMBOPHILIA; UPREGULATION; VASCULAR RESISTANCE; VASOCONSTRICTION; VENOUS THROMBOEMBOLISM; VESSEL;

CARDIOVASCULAR DISEASE; INTRAUTERINE GROWTH RESTRICTION; PREECLAMPSIA; PREGNANCY LOSS; PRETERM LABOUR;

ABORTION, HABITUAL; CARDIOVASCULAR DISEASES; FEMALE; FETAL GROWTH RETARDATION; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; MENOPAUSE; OBSTETRIC LABOR, PREMATURE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS;

EID: 84890226979     PISSN: 17540453     EISSN: 17540461     Source Type: Journal    
DOI: 10.1177/1754045313495675     Document Type: Review

References (60)

1. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women - 2011 update: a guideline from the american heart association. Circulation 2011; 123: 1243-1262.
2. Scarborough P, Bhatnagar P, Wickramasinghe K, et al. Coronary heart disease statistics. Department of Public Health, University of Oxford (ed.). London: Bristish Heart Foundation Health Promotion Research Group, 2010.
3. Mosca L, Barrett-Connor E and Wenger NK. Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation 2011; 124: 2145-2154.
4. Gorodeski GI. Update on cardiovascular disease in postmenopausal women. Best Pract Res Clin Obstet Gynaecol 2002; 16: 329-355.
5. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980- 2000. N Engl J Med 2007; 356: 2388-2398.
6. Lloyd-Jones D, Adams RJ, Brown TM, et al. Executive summary: heart disease and stroke statistics - 2010 update: a report from the American heart association. Circulation 2010; 121: 948-954.
7. Parikh NI. Sex differences in the risk of cardiovascular disease. BMJ 2011; 343: d5526.
8. Vaidya D, Becker DM, Bittner V, et al. Ageing, menopause, and ischaemic heart disease mortality in England, Wales, and the United States: modelling study of national mortality data. BMJ 2011; 343: d5170.
9. Bellamy L, Casas JP, Hingorani AD, et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007; 335: 974.
10. McDonald SD, Malinowski A, Zhou Q, et al. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 2008; 156: 918-930.
11. Smith GC, Wood AM, Pell JP, et al. Recurrent miscarriage is associated with a family history of ischaemic heart disease: a retrospective cohort study. BJOG 2011; 118: 557-563.
12. Smith GC, Pell JP and Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001; 357: 2002-2006.
13. Smith GD, Whitley E, Gissler M, et al. Birth dimensions of offspring, premature birth, and the mortality of mothers. Lancet 2000; 356: 2066-2067.
14. Cuevas AM and Germain AM. A failed pregnancy stress test: a new and under-recognized cardiovascular risk factor. Curr Atheroscler Rep 2011; 13: 285-286.
15. Sattar N, Greer IA, Rumley A, et al. A longitudinal study of the relationships between haemostatic, lipid, and oestradiol changes during normal human pregnancy. Thromb Haemost 1999; 81: 71-75.
16. Sattar N and Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002; 325: 157-160.
17. Ness RB, Harris T, Cobb J, et al. Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med 1993; 328: 1528-1533.
18. D' Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 743-753.
19. Eaker ED, Packard B and Thom TJ. Epidemiology and risk factors for coronary heart disease in women. Cardiovasc Clin 1989; 19: 129-145.
20. Hodis HN, Collins P, Mack WJ, et al. The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective. Climacteric 2012; 15: 217-228.
21. Yanes LL and Reckelhoff JF. Postmenopausal hypertension. Am J Hypertens 2011; 24: 740-749.
22. Lobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008; 60: 10-18.
23. Stevenson JC. A woman's journey through the reproductive, transitional and postmenopausal periods of life: impact on cardiovascular and musculo-skeletal risk and the role of estrogen replacement. Maturitas 2011; 70: 197-205.
24. Mendelsohn ME and Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801-1811.
25. Vlachopoulos C, Aznaouridis K and Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and metaanalysis. J Am Coll Cardiol 2010; 55: 1318-1327.
26. Vlachopoulos C, Aznaouridis K, O'Rourke MF, et al. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010; 31: 1865-1871.
27. Rossi P, Frances Y, Kingwell BA, et al. Gender differences in artery wall biomechanical properties throughout life. J Hypertens 2011; 29: 1023-1033.
28. Gompel A, Boutouyrie P, Joannides R, et al. Association of menopause and hormone replacement therapy with large artery remodeling. Fertil Steril 2011; 96: 1445-1450.
29. Robson SC, Hunter S, Boys RJ, et al. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 1989; 256: H1060-H1065.
30. Capeless EL and Clapp JF. Cardiovascular changes in early phase of pregnancy. Am J Obstet Gynecol 1989; 161: 1449-1453.
31. Chapman AB, Abraham WT, Zamudio S, et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 1998; 54: 2056-2063.
32. Parikh NI, Lloyd-Jones DM, Ning H, et al. Association of number of live births with left ventricular structure and function. The multi-ethnic study of atherosclerosis (MESA). Am Heart J 2012; 163: 470-476.
33. Hausvater A, Giannone T, Sandoval YH, et al. The association between preeclampsia and arterial stiffness. J Hypertens 2012; 30: 17-33.
34. Yinon Y, Kingdom JC, Odutayo A, et al. Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: insights into future vascular risk. Circulation 2010; 122: 1846-1853.
35. Williams D. Long-term complications of preeclampsia. Semin Nephrol 2011; 31: 111-122.
36. Germain AM, Romanik MC, Guerra I, et al. Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension 2007; 49: 90-95.
37. Kharazmi E, Dossus L, Rohrmann S, et al. Pregnancy loss and risk of cardiovascular disease: a prospective population-based cohort study (EPIC-Heidelberg). Heart 2011; 97: 49-54.
38. Rai R and Regan L. Recurrent miscarriage. Lancet 2006; 368: 601-611.
39. Carrington B, Sacks G and Regan L. Recurrent miscarriage: pathophysiology and outcome. Curr Opin Obstet Gynecol 2005; 17: 591-597.
40. de Kleijn MJ, van der Schouw YT and van der Graaf Y. Reproductive history and cardiovascular disease risk in postmenopausal women: a review of the literature. Maturitas 1999; 33: 7-36.
41. De Paco C, Kametas N, Rencoret G, et al. Maternal cardiac output between 11 and 13 weeks of gestation in the prediction of preeclampsia and small for gestational age. Obstet Gynecol 2008; 111: 292-300.
42. Bosio PM, McKenna PJ, Conroy R, et al. Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol 1999; 94: 978-984.
43. Melchiorre K, Sutherland GR, Liberati M, et al. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension 2011; 58: 709-715.
44. Savvidou MD, Hingorani AD, Tsikas D, et al. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 2003; 361: 1511-1517.
45. Savvidou MD, Kaihura C, Anderson JM, et al. Maternal arterial stiffness in women who subsequently develop preeclampsia. PLoS One 2011; 6: e18703.
46. Kaihura C, Savvidou MD, Anderson JM, et al. Maternal arterial stiffness in pregnancies affected by preeclampsia. Am J Physiol Heart Circ Physiol 2009; 297: H759-H764.
47. Mangos GJ, Spaan JJ, Pirabhahar S, et al. Markers of cardiovascular disease risk after hypertension in pregnancy. J Hypertens 2012; 30: 351-358.
48. Fraser A, Nelson SM, Macdonald-Wallis C, et al. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation 2012; 125: 1367-1380.
49. Duvekot JJ, Cheriex EC, Pieters FA, et al. Maternal volume homeostasis in early pregnancy in relation to fetal growth restriction. Obstet Gynecol 1995; 85: 361-367.
50. Duvekot JJ, Cheriex EC, Pieters FA, et al. Severely impaired fetal growth is preceded by maternal hemodynamic maladaptation in very early pregnancy. Acta Obstet Gynecol Scand 1995; 74: 693-697.
51. Sattar N, Greer IA, Galloway PJ, et al. Lipid and lipoprotein concentrations in pregnancies complicated by intrauterine growth restriction. J Clin Endocrinol Metab 1999; 84: 128-130.
52. Melchiorre K, Sutherland GR, Liberati M, et al. Maternal cardiovascular impairment in pregnancies complicated by severe fetal growth restriction. Hypertension 2012; 60: 437-443.
53. Barker DJ. Fetal programming of coronary heart disease. Trends Endocrinol Metab 2002; 13: 364-368.
54. Burke SD, Barrette VF, David S, et al. Circulatory and renal consequences of pregnancy in diabetic NOD mice. Placenta 2011; 32: 949-955.
55. Anderson JM, Savvidou MD, Kaihura C, et al. Maternal arterial stiffness in pregnancies affected by type 1 diabetes mellitus. Diabet Med 2009; 26: 1135-1140.
56. Savvidou MD, Anderson JM, Kaihura C, et al. Maternal arterial stiffness in pregnancies complicated by gestational and type 2 diabetes mellitus. Am J Obstet Gynecol 2010; 203: 274 e1-274 e7.
57. Magnussen EB, Vatten LJ, Myklestad K, et al. Cardiovascular risk factors prior to conception and the length of pregnancy: population-based cohort study. Am J Obstet Gynecol 2011; 204: 526 e1-526 e8.
58. Catov JM, Newman AB, Roberts JM, et al. Preterm delivery and later maternal cardiovascular disease risk. Epidemiology 2007; 18: 733-739.
59. Clarkson TB and Appt SE. Controversies about HRT - lessons from monkey models. Maturitas 2005; 51: 64-74.
60. Rosano G, Vitale C, Spoletini I, et al. Cardiovascular health in the menopausal woman: impact of the timing of hormone replacement therapy. Climacteric 2012; 15: 299-305.